Raf Inhibitors Target Ras Spatiotemporal Dynamics

被引:49
|
作者
Cho, Kwang-jin [2 ]
Kasai, Rinshi S. [3 ]
Park, Jin-Hee [2 ]
Chigurupati, Sravanthi [2 ]
Heidorn, Sonja J. [1 ]
van der Hoeven, Dharini [2 ]
Plowman, Sarah J. [2 ]
Kusumi, Akihiro [3 ,4 ]
Marais, Richard [1 ]
Hancock, John F. [2 ]
机构
[1] Inst Canc Res, Sect Cell & Mol Biol, Signal Transduct Team, London SW3 6JB, England
[2] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
[3] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan
[4] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068507, Japan
关键词
K-RAS; NANOCLUSTER FORMATION; TUMOR PROGRESSION; LIPID RAFTS; H-RAS; ACTIVATION; BRAF; ERK; DEPENDENCE; PROTEINS;
D O I
10.1016/j.cub.2012.03.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The lateral segregation of Ras proteins into transient plasma membrane nanoclusters is essential for high-fidelity signal transmission by the Ras mitogen-activated protein kinase (MAPK) cascade. In this spatially constrained signaling system, the dynamics of Ras nanocluster assembly and disassembly control MAPK signal output. Results: We show here that BRaf inhibitors paradoxically activate CRaf and MAPK signaling in Ras transformed cells by profoundly dysregulating Ras nanocluster dynamics. Specifically, BRaf inhibitors selectively enhance the plasma membrane nanoclustering of oncogenic K-Ras and N-Ras but have no effect on H-Ras nanoclustering. Raf inhibitors are known to drive the formation of stable BRaf-CRaf and CRaf-CRaf dimers. Our results demonstrate that the presence of two Ras-binding domains in a single Raf dimer is sufficient and required to increase Ras nanoclustering, indicating that Raf dimers promote K- and N-Ras nanocluster formation by crosslinking constituent Ras proteins. Ras crosslinking increases the fraction cif K-Ras and N-Ras in their cognate nanoclusters, leading to an increase in MAPK output from the plasma membrane. Intriguingly, increased MAPK signaling in BRaf inhibited cells is accompanied by significantly decreased Akt activation. We show that this signal pathway crosstalk results from a novel mechanism of competition between stabilized Raf dinners and p110 alpha for recruitment to Ras nanoclusters. Conclusions: Our findings reveal that BRaf inhibitors disrupt Ras nanocluster dynamics with significant, yet divergent, consequences for MAPK and PI3K signaling.
引用
收藏
页码:945 / 955
页数:11
相关论文
共 50 条
  • [1] Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway
    Waldmann, H
    Karaguni, IM
    Carpintero, M
    Gourzoulidou, E
    Herrmann, C
    Brockmann, C
    Oschkinat, H
    Müller, O
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (04) : 454 - 458
  • [2] RAS/RAF/MEK Inhibitors in Oncology
    Rusconi, P.
    Caiola, E.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (08) : 1164 - 1176
  • [3] Yeast screens for inhibitors of Ras-Raf interaction and characterization of MCP inhibitors of Ras-Raf interaction
    Khazak, Vladimir
    Kato-Stankiewicz, Juran
    Tamanoi, Fuyu
    Golemis, Erica A.
    REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 612 - 629
  • [4] Interplay between RAF inhibitors and RAS.
    Zhang, Ying
    Bollag, Gideon
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 29 - 29
  • [5] RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
    Ting Jin
    Hugo Lavoie
    Malha Sahmi
    Maud David
    Christine Hilt
    Amy Hammell
    Marc Therrien
    Nature Communications, 8
  • [6] Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes
    Zeng, J
    Treutlein, HR
    Simonson, T
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1999, 35 (01) : 89 - 100
  • [7] RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
    Jin, Ting
    Lavoie, Hugo
    Sahmi, Malha
    David, Maud
    Hilt, Christine
    Hammell, Amy
    Therrien, Marc
    NATURE COMMUNICATIONS, 2017, 8
  • [8] Exploring the role of Raf-CRD in the dynamics of Ras/Raf at the membrane
    Kien Nguyen
    Gnanakaran, S.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 224A - 224A
  • [9] Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex
    Vasta, James D.
    Michaud, Ani
    Zimprich, Chad A.
    Beck, Michael T.
    Swiatnicki, Matthew R.
    Zegzouti, Hicham
    Thomas, Morgan R.
    Wilkinson, Jennifer
    Crapster, J. Aaron
    Robers, Matthew B.
    CELL CHEMICAL BIOLOGY, 2023, 30 (11) : 1354 - +
  • [10] Rationale for ras and raf-kinase as a target for cancer therapeutics
    Nottage, M
    Siu, LL
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (25) : 2231 - 2242